RXQ Compounding LLC recalls HYDROMORPHONE 0.2MG/ML IN NACL 0.9% SYR (C-II) , [a) 50 ML NDC 70731-0114-89; b) 55 ML NDC 70731-0114-95] per syringe, R
Recalled August 14, 2019 · FDA recall D-1665-2019 · RXQ Compounding
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
N/A
Sold at
Nationwide USA
Description
Lack of Assurance of Sterility
Product
HYDROMORPHONE 0.2MG/ML IN NACL 0.9% SYR (C-II) , [a) 50 ML NDC 70731-0114-89; b) 55 ML NDC 70731-0114-95] per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.
Manufacturer(s)
RXQ Compounding LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →